Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase II
Gem Pharmaceuticals Announces Enrollment Of Initial Patients In Its Phase 2 Clinical Trial To Assess The Efficacy And Safety Of GPX-150 In Sarcoma Patients 1/23/2015 10:18:55 AM
GlaxoSmithKline (GSK)'s Long-Awaited Ebola Vaccine Due to Arrive in Liberia 1/23/2015 5:57:09 AM
Progenics Pharmaceuticals, Inc. (PGNX) Relaunches Pivotal Trial Of AZEDRA™ In Pheochromocytoma 1/23/2015 7:29:51 AM
Medivation, Inc. (MDVN) Release: Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Significant Increase In PFS As Compared To Bicalutamide In Metastatic Prostate Cancer 1/22/2015 11:22:58 AM
Alexza Pharmaceuticals, Inc. (ALXA) Initiates Phase 2a Study Of AZ-002 (Staccato® alprazolam) In Epilepsy Patients 1/22/2015 8:14:04 AM
CytRx Corporation (CYTR) Announces Overall Survival Results From Its Global Phase 2b Clinical Trial Of Aldoxorubicin In Soft Tissue Sarcoma 1/22/2015 8:12:56 AM
BioMarin (BMRN), Sarepta (SRPT) Rivalry Gets Nasty in Battle Over Data 1/19/2015 6:07:38 AM
PharmaEngine, Inc. Announces Phase 2 PEPCOL Study Presented At The 2015 American Society of Clinical Oncology GI Of PEP02 (MM-398) In Combination With 5-FU/LV In Unresectable Metastatic Colorectal Cancer 1/21/2015 10:58:16 AM
Ocular Therapeutix, Inc. (OCUL) Enrolls First Patient In Phase 2 Clinical Trial For Sustained Release Dexamethasone For The Treatment Of Dry Eye Disease 1/21/2015 8:13:47 AM
BioInvent (BOVNF)’s Bi-1206 Antibody To Enter Collaborative Phase 1/2 Trial Funded And Conducted By Cancer Research UK, CRT And LLR 1/20/2015 11:08:09 AM
AM-Pharma Starts Adaptive Phase 2 Trial Of Recap In Acute Kidney Injury 1/20/2015 10:02:50 AM
Aduro Biotech Reports Long-Term Survival And Immune Biomarker Data From Phase 2 Clinical Trial Of Its Immuno-Oncology Regimen In Patients With Pancreatic Cancer 1/20/2015 9:04:10 AM
TauRx Therapeutics Release: First Evidence Of Potential Efficacy Of Tau Aggregation Inhibitor Therapy In Alzheimer's Disease 1/20/2015 7:06:25 AM
Spark Therapeutics Initiates Phase 1/2 Clinical Trial Of SPK-CHM For Choroideremia, Expanding Its Pipeline Of Potential Treatments For Rare, Blinding Conditions 1/20/2015 7:03:57 AM
Invion Limited Shows Off Positive Phase 2 Data for Smokers Trying to Quit 1/19/2015 7:25:58 AM
1234567
//-->